Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 210-216

  Lunel, F ^a,b   Cacoub, P ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Autoantibodies; Autoimmune hepatitis; Glomerulonephritis; Hepatitis C virus; Interferon; Lichen planus; Mixed cryoglobulinemia; Ribavirin; Sjogren syndrome; Thyroid diseases; Treatment; Vasculitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; CORTICOSTEROID; CRYOGLOBULIN; HEPATITIS C ANTIBODY; METHYLPREDNISOLONE; MICROSOME ANTIBODY; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; SMOOTH MUSCLE ANTIBODY; VIRUS RNA;

ANTIBODY TITER; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CRYOGLOBULINEMIA; HEPATITIS C; HUMAN; IMMUNE COMPLEX DEPOSITION; KIDNEY MICROSOME; LICHEN PLANUS; LIVER MICROSOME; PRIORITY JOURNAL; SIALOADENITIS; THYROIDITIS;

EID: 0033430352     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80404-8     Document Type: Conference Paper

References (49)

1. Gumber SC, Clopra S. Hepatitis C: A multifaced disease. Review of extrahepatic manifestations. Ann Intern Med 1995: 123: 615620.
2. Pawlotsky JM, Ben Hayia M, André C, Voisin MC, Intrator L, Roudot-Thoraval F et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994: 19: 841-848.
3. Lunel F. Hépatite C et anomalies immunologiques. Gastroenterol Clin Biol 1994: 18: 829-838.
4. Lunel F. HCV and autoimmunity: fortuitous association or reality? Gastroenterology 1994: 107: 1550-1555 (Editorial).
5. Haddad J, Deny P, Munz-Gotheil C, Ambrosini J-C, Trinchet JC, Pateron D et al. Lymphocytic sialadenitis of Sjögren's syn-drome associated with chronic hepatitis C virus liver disease. Lancet 1992: 339: 321-323.
6. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994: 106: 1291-1300.
7. Czaja AL. Extrahepatic immunologie features of chronic viral hepatitis. Dig Dis Sei 1997: 15: 125-144.
8. Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992: 16: 630-636.
9. Abuaf N, Lunel F, Giral Ph, Borotto E, Laperche S, Poupon R et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993: 18: 359-364.
10. Saracco G, Touscoz A, Durazzo M, Rosina F, Donegani E, Chiandussi L et al. Antibodies and response to alpha-interferon in patients with chronic viral hepatitis. J Hepatol 1990: 11: 339343.
11. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type I in adults with chronic active hepatitis. Gastroenterology 1992: 103: 12901295.
12. Garcia-Bury L, Garcia-Monzon C, Rodriguez S, Borque MJ, Garcia Sanchez A, Iglesias R et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995: 108: 1770-1777.
13. Suva MO, Reddy KR, Jeffers LJ, Hill M, Schiff ER. Interferoninduced chronic active hepatitis. Gastroenterology 1991: 101: 840-842.
14. Weber P, Wiederman K-H, Klein R, Walter E, Blum HE, Berg PA. Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon. J Hepatol 1994: 20: 321-338.
15. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Auto-immune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 1992: 116 51-53.
16. Muratori L, Zauli D, Giostra F, Ballardini G, Lenzi M, Cassani F et al. LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment. J Hepatol 1993: 17: 259260.
17. Me Farlane IG. Immunological abnormalities and hepatotropic viral infections. Clin Exp Immunol 1992: 87: 337-339.
18. Schrumpf E, Elgjo K, Fausa O, Haukenes G, Kvale D, Rollag H. The significance of anti-hepatitis C virus antibodies measured in chronic liver disease. Scand J Gastroenterol 1990: 25: 1169-1174.
19. Czaja Al, Taswell HF, Rakela J, Schimek C. Frequency and significance of antibody to hepatitis C virus in severe corticosteroidtreated autoimmune chronic active hepatitis. Mayo Clin Proc 1991: 66: 572-582.
20. Schvarcz R, Von Sydow M, Weiland O. Autoimmune chronic active hepatitis: Changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment. Scand J Gastroenterol 1990:25: 1175-1180.
21. Borotto E, Lunel F, Valla D, Abuaf N, Perrin M, Bousquet JC et al. Prevalence et interpretation des anticorps anti-organites non spécifiques du foie au cours des hépatites chroniques virales C. Gastroenterol Clin Biol 1994: 18: 813-818.
22. Moreno RM, Rua MJ, Carreno V, Quiroya JA, Manns M. Autoimmune hepatitis type 2 manifested during interferon therapy in children. J Hepatol 1991: 12: 265-266.
23. Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, et al. Interferon therapy in liver/kidney microsomal antibody type I-positive patients with chronic hepatis. C. J. Hepatol 1994:21: 199-203.
24. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II Cryoglobulinemia. N Engl J Med 1992: 327: 1490-1495.
25. Apartis E, Leger JM, Musset L, Gugenheim M, Cacoub P, Lyon Caen O et ai. Peripheral neuropathy associated with essential mixed Cryoglobulinemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry 1996: 60: 661-666.
26. Dupin N, Chosidow O, Lunel F, Cacoub P, Musset Lcresta P et al. Essential mixed cryoglobulinemia. A comparative study of dermatologie manifestations in patients infected with hepatitis C virus. Arch Dermatol 1995: 131: 1124-1127.
27. Agnello V. An immunological perspective on hepatitis C virus infection. Hepatology 1997: 26: 1375-1379.
28. Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathïc mixed cryoglobulinemia with alpha interferon. Am J Med 1987: 83: 726-730.
29. Casato M, Lagana B, Antonelli G, Dianzani F, Bonomo L. Long-term results of therapy with Interferon-alpha for type II essential mixed cryoglobulinemia. Blood 1991: 78: 3142-3147.
30. Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis virus C infection. Blood 1997: 90: 3865-3873.
31. Ferri C, Marzo M, Longombardo G, Lombardini F, La Civita L, Vanacore R et al. Interferon alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993: 81: 1132-1136.
32. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994: 330: 751-756.
33. Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchiulo V, Lacobelli AR et al. Natural interferon alpha versus its combination with 6-methyl-prednisolone on the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 1994: 84: 3336-3343.
34. Cresta P, Musset L, Frangeul L, Cacoub P, Vitour D, Poynard T et al. Response to interferon alpha therapy and disappearence of cryoglobulinemia in patients infected by hepatitis C virus. Gut 1999: in press.
35. Durand JM, Cacoub P, Lunel-Fabiani F, Cosserat J, Cretel E, Kaplanski G et al. Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol 1998: 25(6): 1115-1117.
36. Zuckerman E, Slobodan G, Tamir A, Nashitz I, Tsykounov I, Eldar I et al. Treatment of refractory, symptomatic HCV-related mixed cryoglobulinemia (MC) with ribavirin and interferon alpha. Hepatology 1998: 284: 375 (abstract 846).
37. Johnson RJ, Gretch DR, Yamabe H, Han J, Bacchi CE, Hartwell P et al. Membrano-proliferative glomerulonephritis associated with hepatitis C virus. N Engl J Med 1993: 328: 465-470.
38. Lisker-Melman M, Webb D, Di Bisceglie AM, Kassianides C, Martin P, Rustgi V et al. 3H: Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon. Ann Intern Med 1989: 11: 479-183.
39. Cacoub P, Gatel A, Maisonobe T, Thibalt V, Hausfater P, Servan J et al. Polyarteritis nodosa type versus symptomatic cryoglobulinemia in hepatitis C patients, Arthritis Rheum 1998: 41: S 245 (abstract).
40. Cacoub P. Virus de l'hépatite C et atteintes neurologiques. Gastroenterol Clin Biol 1998: 22: 889-890.
41. Doutre MS, Beylot C, Couzigou P, Long P, Royer P, Beylot J. Lichen planus and virus C hepatitis: Disappearance of the lichen under interferon alpha therapy. Dermatology 1992: 184: 229 (letter).
42. Tran A, Quaranta J-F, Benzaken S, Thiers V, Chau HT, Hastier P et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993: 18: 253-257.
43. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 1992: 102: 2155-2160.
44. Marcellin P, Pouteau M, Benhamou J-P. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J. Hepatol 1995: 22: 364-369.
45. Dupin N, Chosidow, O, Frances C, Boisnic S, Lunel F, Opolon P et al. Lichen planus after alpha-interferon therapy for chronic hepatitis. C. Eur J Dermatol 1994: 4: 435-436.
46. Papini M, Bruni PL, Bettacchi A, Libérât F. Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alpha-interferon. Int J Dermatol 1994: 33: 221222 (letter).
47. Barreca T, Corsini G, Franceschini R, Gambini C, Garibaldi A, Rolandi E. Lichen planus induced by interferon-a-2a therapy for chronic active hepatitis C. Eur J Gastroenterol Hepatol 1995: 7: 367-368.
48. Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermuller KH. Exacerbation of liehen planus during interferon alpha-2a therapy for chronic active hepatitis C. Gastroenterology 1993: 104: 903-905.
49. Georgetson MJ, Yarze JC, Lalos AT, Webster GF, Manin P. Exacerbation of psoriasis due to interferon alpha treatment of chronic active hepatitis. Am J Gastroenterol 1993: 88: 1756-1758.